GLP-1 Memberships
Metabolic care, simplified.
Predictable monthly pricing on physician-supervised tirzepatide and semaglutide therapy — with the clinical oversight you deserve. Medication is prescribed only when a licensed clinician determines it is appropriate for you.
Two Programs
Choose your protocol.
Tirzepatide membership pricing is based on your prescribed weekly dose. Weekly microdosing at 2.5mg starts at $99/month; the 4.25mg weekly tier starts at $149/month. Higher tiers and personalized titration plans are available through your clinician.
Tirzepatide Membership
Provider-supervised tirzepatide (dual GIP/GLP-1) therapy with predictable monthly pricing by dose tier.
- Monthly tirzepatide supply once prescribed
- Provider-supervised dose titration
- Secure messaging for side effects & questions
- Quarterly progress check-ins
- Included annual DEXA scan (membership benefit)
Advanced Metabolic Membership
Higher-dose tirzepatide or semaglutide tiers for patients who need closer metabolic oversight and higher-touch clinical support.
- Monthly medication supply once prescribed
- Provider-supervised dose titration
- Priority messaging access
- Quarterly progress check-ins
- Included annual DEXA scan (membership benefit)
Compliance & Disclaimers
- • Membership pricing reflects starting dose tiers; final pricing depends on prescribed dose and titration plan.
- • Treatment is not guaranteed and requires a comprehensive evaluation by an independently licensed clinician. Pricing shown does not include the required medical consultation.
- • Indication: Prescription weight-management medications may be prescribed off-label for chronic weight management in adults who meet clinical criteria; they are not approved by the FDA for any indication.
- • Do not use if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), are pregnant or breastfeeding, or have a history of pancreatitis or severe gastrointestinal disease. Disclose all medications, supplements, and conditions.
- • Common side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, and injection-site reactions. Serious risks include pancreatitis, gallbladder disease, kidney injury, and (in animal studies) thyroid C-cell tumors.
- • FDA shortage status: Semaglutide and tirzepatide were removed from the FDA drug-shortage list in 2024. 503A compounding of these molecules is now limited to specific clinical-need exceptions (e.g. documented allergy or a commercially unavailable dose) as determined by the prescribing clinician.
- • Any compounded medication is prepared and dispensed by an independently licensed 503A or 503B U.S. pharmacy and is not an FDA-approved finished drug product. Body Tonic RX does not offer compounded preparations that are not permitted under current FDA compounding policy.
- • Geographic availability based on clinician licensure. Medication ships only after clinical approval.
Have questions about candidacy or safety? Talk to a clinician before starting any prescription therapy.